David Walling

1 presentation

• T115. OPEN-LABEL, RANDOMIZED STUDY TO ASSESS SAFETY AND EFFICACY OF SLOW AND ACCELERATED SWITCHING TO XANOMELINE/TROSPIUM FROM STANDARD OF CARE ATYPICAL ANTIPSYCHOTICS IN PARTICIPANTS WITH SCHIZOPHRENIA

  2026 ASCP Annual Meeting